Focus Stocks
Playing the Momentum Building in JNJ
Published on Thursday, 11 March 2010 08:16 Written by Christopher Lynn
New York, March 11th (TradersHuddle.com) - Shares of Johnson and Johnson (NYSE:JNJ) closed the trading session at $64.29 placing the price action in a very tight range, given that calculated support is set at $62.22 and the calculated resistance based on an algorithm of peaks and troughs is set at $65.41
Johnson & Johnson (NYSE:JNJ) manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, Tylenol, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world. The consumer healthcare products company was founded in 1886 and is based in New Brunswick, NJ.
JNJ's stock price action indicates that both sellers and buyers are materializing very close to each other, which is indicative to a momentum building area, as the stock can resolve by breaking out of the tight range that developed.
Traders wanting to establish a position should place close attention to JNJ's price action, as any movement outside its predefined range of $62.22 and $65.41 could grab the attention of momentum buyers, looking for a big movement in the price of the stock. Traders need to be aware that tight range resolution works both ways, hence, a move below support at $62.22 could spark above average selling. A tiered approach can be a good way to approach starting a position in JNJ's, by establishing a starter position while the stock is in the tight range, and then adding to the position as it breaks and closes above resistance.
Related Articles
- JNJ Close to Probable Support
- JNJ Had a Bearish Engulfing Candle
- JNJ Earnings Preview
- VisionCare Announces Close of Series E Expansion Financing and Board Changes
- Fish & Richardson Attorneys Tom Melsheimer, Tommy Jacks Help Whistleblower, State of Texas Earn Historic Settlement in Lawsuit Over Risperdal Medication
- JP Morgan - Worst Performing Dow Component
- Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2011 Financial Results
- Biosense Webster Completes Enrollment in Ground-Breaking SMART-AF Trial
- Biosense Webster Announces FDA approval of the THERMOCOOL® SF Catheter in the United States
- Biosense Webster to offer a Comprehensive Electrophysiology (EP) Lab Solution
Related Partner Headlines
- First Global Downgrades Johnson & Johnson to Market Perform - Benzinga
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Cramer: 5 Earnings Trades the Market Always Gets Wrong - TheStreet.com
- Charges Eat Into Johnson & Johnson Profit - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Higher - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Winner - TheStreet.com
- Dow Today: Johnson & Johnson (JNJ) Lower - TheStreet.com
- Johnson & Johnson (JNJ): Today's Featured Drugs Winner - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
A Plea for Help From 401(k) Land - TheStreet.com -
February Webinar: Exit Strategies - TheStreet.com -
UPDATE: Collins Stewart Downgrades Morgan Stanley to Hold - Benzinga -
Want Your Kids to Do Their Chores? Use Technology - TheStreet.com -
Rambus Up 12% After Signing Patent Agreement - Benzinga -
UPDATE: J.P. Morgan Raises Harman International PT - Benzinga -
UPDATE: Charles Stanley Downgrades Carnival to Hold - Benzinga -
UPDATE: Charles Stanley Downgrades Carnival to Hold - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,878.20 Trade time:4:05PM EST Value change:▲33.07 (0.26%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,347.05 Trade time:4:32PM EST Value change:0.00 (0.00%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,904.08 Trade time:5:16PM EST Value change:0.00 (0.00%)In The Wires
-
NEI to Showcase New High-Performance Security Appliance Technologies at RSA® Conference 2012 -
MasterCard Establishes Relationship with Silver Tail Systems to Combat Online Fraud -
Parlux Sets Date for Its Unaudited Fiscal 2012 3rd Quarter Results and Conference Call -
AUXILIO to Exhibit at HIMSS12 Knowledge Center in Las Vegas -
ChemoCentryx Announces Pricing of Initial Public Offering -
Experian Provides Clarity Services with Identity Verification and Fraud Detection Capabilities for the Subprime Market -
Alpine Global Premier Properties Fund Announces a New Share Repurchase Plan -
Datawatch and Laserfiche Partner to Enable World Class ECM Analytics










